Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yun Nan Hou

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Organic & Biomolecular Chemistry|January 15, 2019
Solution-phase total synthesis of teixobactinBowen Gao, Sigui Chen, Yun Nan Hou, et al.
Analytica Chimica Acta|June 17, 2018
Nanobody-based dual epitopes protein identification (DepID) assay for measuring soluble CD38 in plasma of multiple myeloma patientsTing Li, Song Lu Li, Cheng Fang, et al.
The FEBS Journal|July 2, 2021
Acidic pH irreversibly activates the signaling enzyme SARM1Yong Juan Zhao, Wei Ming He, Zhi Ying Zhao, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 20, 2017
Cytosolic interaction of type III human CD38 with CIB1 modulates cellular cyclic ADP-ribose levelsJun Liu, Yong Juan Zhao, Wan Hua Li, et al.
The Journal of Biological Chemistry|April 11, 2018
CD38 produces nicotinic acid adenosine dinucleotide phosphate in the lysosomeCheng Fang, Ting Li, Ying Li, et al.
Molecular Pharmaceutics|September 7, 2018
Anti-Multiple Myeloma Activity of Nanobody-Based Anti-CD38 Chimeric Antigen Receptor T CellsNa An, Yun Nan Hou, Qiao Xia Zhang, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 5, 2021
ImmunoPET imaging of multiple myeloma with [<sup>68</sup>Ga]Ga-NOTA-Nb1053Cheng Wang, Yumei Chen, Yun Nan Hou, et al.
Nature Communications|December 22, 2022
A conformation-specific nanobody targeting the nicotinamide mononucleotide-activated state of SARM1Yun Nan Hou, Yang Cai, Wan Hua Li, et al.
Scientific Reports|June 3, 2016
Immuno-targeting the multifunctional CD38 using nanobodyTing Li, Shali Qi, Mandy Unger, et al.
Elife|May 4, 2021
Permeant fluorescent probes visualize the activation of SARM1 and uncover an anti-neurodegenerative drug candidateWan Hua Li, Ke Huang, Yang Cai, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Organic & Biomolecular Chemistry|January 15, 2019
Solution-phase total synthesis of teixobactinBowen Gao, Sigui Chen, Yun Nan Hou, et al.
Analytica Chimica Acta|June 17, 2018
Nanobody-based dual epitopes protein identification (DepID) assay for measuring soluble CD38 in plasma of multiple myeloma patientsTing Li, Song Lu Li, Cheng Fang, et al.
The FEBS Journal|July 2, 2021
Acidic pH irreversibly activates the signaling enzyme SARM1Yong Juan Zhao, Wei Ming He, Zhi Ying Zhao, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 20, 2017
Cytosolic interaction of type III human CD38 with CIB1 modulates cellular cyclic ADP-ribose levelsJun Liu, Yong Juan Zhao, Wan Hua Li, et al.
The Journal of Biological Chemistry|April 11, 2018
CD38 produces nicotinic acid adenosine dinucleotide phosphate in the lysosomeCheng Fang, Ting Li, Ying Li, et al.
Molecular Pharmaceutics|September 7, 2018
Anti-Multiple Myeloma Activity of Nanobody-Based Anti-CD38 Chimeric Antigen Receptor T CellsNa An, Yun Nan Hou, Qiao Xia Zhang, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 5, 2021
ImmunoPET imaging of multiple myeloma with [<sup>68</sup>Ga]Ga-NOTA-Nb1053Cheng Wang, Yumei Chen, Yun Nan Hou, et al.
Nature Communications|December 22, 2022
A conformation-specific nanobody targeting the nicotinamide mononucleotide-activated state of SARM1Yun Nan Hou, Yang Cai, Wan Hua Li, et al.
Scientific Reports|June 3, 2016
Immuno-targeting the multifunctional CD38 using nanobodyTing Li, Shali Qi, Mandy Unger, et al.
Elife|May 4, 2021
Permeant fluorescent probes visualize the activation of SARM1 and uncover an anti-neurodegenerative drug candidateWan Hua Li, Ke Huang, Yang Cai, et al.
Pageof 2